| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
021-61312847; 18021002903 |
| Email: |
3008007409@qq.com |
| Products Intro: |
Product Name:Otilimab (anti-GM-CSF)
CAS:1638332-55-4
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:5mg Remarks:K10781
|
| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Otilimab
CAS:1638332-55-4
Purity:95% Package:100ug;500ug;1mg
|
Otilimab manufacturers
- Otilimab
-
- $122.00 / 1mg
-
2025-09-11
- CAS:1638332-55-4
- Min. Order:
- Purity: SDS-PAGE:95% SEC-HPLC:95%
- Supply Ability: 10g
|
| | Otilimab Basic information |
| Product Name: | Otilimab | | Synonyms: | Otilimab;Research Grade Otilimab;Otilimab (anti-GM-CSF);GSK 3196165|||MOR103 | | CAS: | 1638332-55-4 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Otilimab Structure]() |
| | Otilimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Otilimab Usage And Synthesis |
| Uses | Otilimab (GSK 3196165) is an anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) human monoclonal antibody. Otilimab neutralises the biological function of GM-CSF by blocking the interaction of GM-CSF with its cell surface receptor[1]. | | References | [1] Senolt L. Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies. F1000Res. 2019 Aug 30;8:F1000 Faculty Rev-1549. DOI:10.12688/f1000research.18688.1 |
| | Otilimab Preparation Products And Raw materials |
|